arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

PRO DEX INC

PDEX
$71.75 ▼ -0.59 (-0.82%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
65 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
72
Health
Good
Bullish
auto_awesome

Analytical Summary

PRO DEX INC shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap
Dividend Yield
Revenue Growth 16.6%
Op. Margin 17.3%
ROIC 4.4%
FCF / Share None
Trailing P/E 79.7x
Price / Book 4.8x
FCF Yield
Debt / Equity 0.37
info Valuation on last close. End-of-day price, Sep 23, 2026.

65-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$20.41M
↑ +16.6%
Net Income Profit after all expenses
$2.86M
↑ +138.7%
Operating Margin Operating profit as % of sales
17.3%
↑ +11.5% 79th
FCF / Share Free cash flow per share
$0.48
↓ -55.9%
Long-Term Debt Long-term obligations
$17.51M
↑ +4245.7%
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
72
Returns
89
Financial Health
68
Cash Quality
36

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 65 quarters